| Good morning Wake-Up Watchlisters! While you're sipping coffee you'll see stocks wavered on Wednesday. Wall Street is preparing for the Federal Reserve's latest announcement, which likely includes raising interest rates another 75 basis points. Investors will assess remarks form Fed Chair Jerome Powell in the aftermath of the rate decision. There's a good possibility for more choppy markets in the days ahead, and if that's the case, have you considered alternative investments? Right now our Head Fundamental Tactician Karim Rahemtulla is showing why our $30 trillion debt bill could trigger the worst recession in 50 years. Click here to learn why you should consider moving your cash into this $3 asset BEFORE November 4, 2022. Here's a look at the top-moving stocks this morning. Arcturus Therapeutics (Nasdaq: ARCT) Arcturus is up 34.03% premarket after the company announced a collaboration with CSL to develop and commercialize self-amplifying mRNA vaccines. Artcurus will receive an upfront payment of $200 million and more than $4 billion in potential development and commercial milestones. It also includes 40% profit sharing for COVID-19 vaccines, up to double digit royalties for influenza, pandemic preparedness and three additional respiratory infectious disease vaccines. The medical sector is often home to major swings in the market. Our friend Alexander Green has predicted major medical revolutions before – and right now he's high on this one company that owns a device he's calling the 'biggest healthcare innovation in half a century.' Click here to unlock this $3 stock. Chegg, Inc. (NYSE: CHGG) Chegg is up 18.90% premarket after the online-learning platform reported fiscal third-quarter revenue and earnings that exceeded expectations. Chegg reported net income of $251.6 million, compared with net income of $6.65 million, in the year-ago quarter. | 
No comments:
Post a Comment